Arcus Biosciences (NYSE:RCUS) said on Thursday that its experimental drug candidate, quemliclustat, has received orphan drug status from the U.S. FDA. Quemliclustat is a type of medication that works ...

Arcus Biosciences announced that the Food and Drug Administration has granted its pancreatic cancer treatment, quemliclustat, with an orphan drug designation. The company said it expects its ongoing ...

FMLAFamily and Medical Leave (FMLA) Please review the Family and Medical Leave Standard and Operating Procedures. To be eligible for FMLA leave, an employee must have: Been employed by the University ...

Response Medical AI: is trust really the issue? Jakob Thrane Mainz Journal of Medical Ethics 2023; 50 349-350 Published Online First: 26 Jul 2023. doi: 10.1136/jme-2023-109414 ...